Sentence examples for cost effectiveness below from inspiring English sources

However, even if active measures could be installed in 100% of the relevant homes, such a policy would have cost effectiveness below £30 000 per QALY only in areas where the mean radon concentration before the installation of basic preventive measures was above about 90 Bq/m.

Both surgeries, at any coverage level, were found to have average cost effectiveness ratios below $Int100, making them among the most cost effective of all interventions examined across different clusters.

All examined strategies had average cost effectiveness ratios below the per capita GDP in Mexico for each DALY averted, making them cost effective by international standards.

These were also the only two interventions with average cost effectiveness ratios below three times GDP per capita in Mexico (both having ratios between $Int2500 and $Int5000).

Bell et al. recently systematically assessed publication bias in health economic evaluations and found that most published analyses report favourable incremental cost effectiveness ratios below 20,000 $/QALY [ 25].

These curves show the fraction of simulations that resulted in cost-effectiveness below a specific willingness-to-pay (WTP) threshold.

Discount rates 4% for costs and 1.5% for QALYs, price level 2007).. Based on these cost-effectiveness ratios only, low budgets would seem to be spent primarily in diabetes patients: In total 17 interventions had average cost-effectiveness below €10,000 per QALY, and 11 of these were for diabetes patients.

Analyses of lower compliance levels indicated that although the number of preventable non-fatal and fatal cardiovascular events would be reduced, the incremental cost effectiveness ratios remained below accepted cost effective thresholds.

The authors also considered that the cost effectiveness of eplerenone was below a "threshold" for acceptable cost effectiveness of $US50 000 per life-year gained (Weintraub et al. 2005).

The results of the cost effectiveness analysis are described below for each intervention, with descriptions of the types and considerations of costs, effectiveness and assumptions.

At a cost of £2 for highly sensitive C reactive protein, the subsequent incremental cost effectiveness ratio decreases to below the lower bound of the NICE threshold (about £19 000 per QALY).